Week in Review
Ariad Pharmaceuticals Inc. raised $224 million in a public stock offering.
Cell Therapeutics Inc. is raising $20 million in a registered direct offering of stock and warrants.
Cerulean Pharma Inc. closed a $15 million Series D financing.
Ember Therapeutics raised $34 million in Series A financing for obesity and diabetes drugs.
ImmusanT Inc. raised $20 million in a Series A round for celiac disease vaccine Nexvax2.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST